Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Apyx Medical Q3 EPS $(0.05) Beats $(0.10) Estimate, Sales $12.877M Beat $12.002M Estimate

Author: Benzinga Newsdesk | November 06, 2025 07:02am
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.10) by 50.98 percent. This is a 64.29 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $12.877 million which beat the analyst consensus estimate of $12.002 million by 7.29 percent. This is a 12.10 percent increase over sales of $11.487 million the same period last year.

Posted In: APYX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist